Gambia vs Israel: Hepatitis B surface antigen (HBsAg) prevalence
Gambia
0.1%
in 2024
Israel
0.1%
in 2024
Gambia rank
101st
Israel rank
101st
Hepatitis B surface antigen (HBsAg) prevalence over time
- Gambia
- Israel
How they compare
Gambia currently reports 0.1% against 0.1% in Israel, a difference of 0.0%.
The two have swapped places 2 times across 10 shared years of data; in 2015 it was Israel ahead.
Gambia ranks 101st and Israel ranks 101st of 194 countries.
Across the 2 decades both report, Gambia averaged higher in 1 and Israel in 1.
Head to head by decade
| Decade | Gambia | Israel | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.2% | 0.3% | 0.1% | Israel |
| 2020s | 0.2% | 0.1% | 0.1% | Gambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Gambia or Israel?
- Gambia, at 0.1% against 0.1% in Israel as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Gambia and Israel?
- 0.0%, with Gambia ahead.
- How many years of comparable data are there for Gambia and Israel?
- 10 years are reported by both, from 2015 to 2024.
- How do Gambia and Israel rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Gambia ranks 101st and Israel ranks 101st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.